Literature DB >> 16094628

Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC).

Tobias Pischon1, Petra H Lahmann, Heiner Boeing, Anne Tjønneland, Jytte Halkjaer, Kim Overvad, Kerstin Klipstein-Grobusch, Jakob Linseisen, Nikolaus Becker, Antonia Trichopoulou, Vassiliki Benetou, Dimitrios Trichopoulos, Sabina Sieri, Domenico Palli, Rosario Tumino, Paolo Vineis, Salvatore Panico, Evelyn Monninkhof, Petra H M Peeters, H Bas Bueno-de-Mesquita, Frederike L Büchner, Börje Ljungberg, Göran Hallmans, Göran Berglund, Carlos Alberto Gonzalez, Miren Dorronsoro, Aurelio Barricarte Gurrea, Carmen Navarro, Carmen Martinez, J Ramón Quirós, Andrew Roddam, Naomi Allen, Sheila Bingham, Kay-Tee Khaw, Rudolf Kaaks, Teresa Norat, Nadia Slimani, Elio Riboli.   

Abstract

Previous studies suggest that obesity is related to increased risk of renal cell carcinoma (RCC); however, only a few studies report on measures of central vs. peripheral adiposity. We examined the association between anthropometric measures, including waist and hip circumference and RCC risk among 348,550 men and women free of cancer at baseline from 8 countries of the European Prospective Investigation into Cancer and Nutrition (EPIC). During 6.0 years of follow-up we identified 287 incident cases of RCC. Relative risks were calculated using Cox regression, stratified by age and study center and adjusted for smoking status, education, alcohol consumption, physical activity, menopausal status, and hormone replacement therapy use. Among women, an increased risk of RCC was conferred by body weight (relative risk [RR] in highest vs. lowest quintile = 2.13; 95% confidence interval [CI] = 1.16-3.90; p-trend = 0.003), body mass index (BMI) (RR = 2.25; 95% CI = 1.14-4.44; p-trend = 0.009), and waist (RR = 1.67; 95% CI = 0.94-2.98; p-trend = 0.003) and hip circumference (RR = 2.30; 95% CI = 1.22-4.34; p-trend = 0.01); however, waist and hip circumference were no longer significant after controlling for body weight. Among men, hip circumference (RR = 0.44; 95% CI = 0.20-0.98; p-trend = 0.03) was related significantly to decreased RCC risk only after accounting for body weight. Height was not related significantly to RCC risk. Our findings suggest that obesity is related to increased risk of RCC irrespective of fat distribution among women, whereas low hip circumference is related to increased RCC risk among men. Our data give further credence to public health efforts aiming to reduce the prevalence of obesity to prevent RCC, in addition to other chronic diseases. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2006        PMID: 16094628     DOI: 10.1002/ijc.21398

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  46 in total

1.  [Prevention of uro-oncological diseases].

Authors:  B J Schmitz-Dräger; G Lümmen; E Bismarck; C Fischer
Journal:  Urologe A       Date:  2012-05       Impact factor: 0.639

Review 2.  Chinese guidelines on the management of renal cell carcinoma (2015 edition).

Authors:  Jun Guo; Jianhui Ma; Yan Sun; Shukui Qin; Dingwei Ye; Fangjian Zhou; Zhisong He; Xinan Sheng; Feng Bi; Dengfeng Cao; Yingxia Chen; Yiran Huang; Houjie Liang; Jun Liang; Jiwei Liu; Wenchao Liu; Yueyin Pan; Yongqian Shu; Xin Song; Weibo Wang; Xiuwen Wang; Xiaoan Wu; Xiaodong Xie; Xin Yao; Shiying Yu; Yanqiao Zhang; Aiping Zhou
Journal:  Ann Transl Med       Date:  2015-11

Review 3.  A systematic review of body fat distribution and mortality in older people.

Authors:  Su-Hsin Chang; Tracey S Beason; Jean M Hunleth; Graham A Colditz
Journal:  Maturitas       Date:  2012-05-16       Impact factor: 4.342

4.  [Renal cell carcinoma].

Authors:  A Haferkamp; D Rohde; S C Müller; H Rübben; M Hohenfellner
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

5.  [Overweight is an advantageous prognostic marker in patients with clear cell kidney cancer].

Authors:  S Waalkes; H Eggers; J Rustemeier; G Wegener; F Jentzmik; M Schrader; R Hofmann; M A Kuczyk; A J Schrader
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

Review 6.  Epidemiology and risk factors for kidney cancer.

Authors:  Wong-Ho Chow; Linda M Dong; Susan S Devesa
Journal:  Nat Rev Urol       Date:  2010-05       Impact factor: 14.432

Review 7.  Contemporary epidemiology of renal cell carcinoma: perspectives of primary prevention.

Authors:  Steffen Weikert; Börje Ljungberg
Journal:  World J Urol       Date:  2010-06       Impact factor: 4.226

8.  Analyzing excess mortality from cancer among individuals with mental illness.

Authors:  Jackson S Musuuza; Marion E Sherman; Kraig J Knudsen; Helen Anne Sweeney; Carl V Tyler; Siran M Koroukian
Journal:  Cancer       Date:  2013-04-12       Impact factor: 6.860

9.  Energy balance, polymorphisms in the mTOR pathway, and renal cell carcinoma risk.

Authors:  Xiang Shu; Jie Lin; Christopher G Wood; Nizar M Tannir; Xifeng Wu
Journal:  J Natl Cancer Inst       Date:  2013-02-02       Impact factor: 13.506

10.  Body mass index and renal cell cancer: the influence of race and sex.

Authors:  Jennifer L Beebe-Dimmer; Joanne S Colt; Julie J Ruterbusch; Gregory R Keele; Mark P Purdue; Sholom Wacholder; Barry I Graubard; Faith Davis; Wong-Ho Chow; Kendra L Schwartz
Journal:  Epidemiology       Date:  2012-11       Impact factor: 4.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.